Legacy Private Trust Co. Moderna, Inc. Transaction History

Legacy Private Trust Co.

$1.46 Billion
Q3 2024

A detailed history of Legacy Private Trust Co. transactions in Moderna, Inc. stock. As of the latest transaction made, Legacy Private Trust Co. holds 11,872 shares of MRNA stock, worth $655,571. This represents 0.05% of its overall portfolio holdings.

Number of Shares

11,872

Previous 17,337 31.52%

Holding current value

$655,571

Previous $2.06 Million 61.47%

% of portfolio

0.05%

Previous 0.15%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$63.64 - $125.14 $347,792 - $683,890	-5,465 Reduced 31.52%	11,872 $793,000
Q2 2024 Jul 12, 2024	SELL	$101.21 - $166.61 $225,192 - $370,707	-2,225 Reduced 11.37%	17,337 $2.06 Million
Q1 2024 Apr 10, 2024	BUY	$85.37 - $115.44 $310,490 - $419,855	3,637 Added 22.84%	19,562 $2.08 Million
Q4 2023 Jan 10, 2024	BUY	$69.51 - $104.43 $755,226 - $1.13 Million	10,865 Added 214.72%	15,925 $1.58 Million
Q3 2023 Oct 11, 2023	SELL	$96.41 - $126.61 $162,643 - $213,591	-1,687 Reduced 25.0%	5,060 $522,000
Q2 2023 Jul 07, 2023	BUY	$118.5 - $160.53 $107,124 - $145,119	904 Added 15.47%	6,747 $819,000
Q1 2023 Apr 12, 2023	BUY	$135.66 - $197.02 $792,661 - $1.15 Million	5,843 New	5,843 $897,000
Q2 2022 Jul 07, 2022	SELL	$117.13 - $176.59 $125,329 - $188,951	-1,070 Reduced 42.31%	1,459 $208,000
Q1 2022 Apr 11, 2022	SELL	$126.46 - $235.05 $51,975 - $96,605	-411 Reduced 13.98%	2,529 $436,000
Q4 2021 Jan 12, 2022	BUY	$225.82 - $368.51 $488,900 - $797,824	2,165 Added 279.35%	2,940 $746,000
Q3 2021 Oct 12, 2021	BUY	$221.9 - $484.47 $171,972 - $375,464	775 New	775 $298,000

Others Institutions Holding MRNA

# of Institutions

1,060

Shares Held

242M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $21.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Private Trust Co., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Private Trust Co. with notifications on news.

Account

Legacy Private Trust Co. Moderna, Inc. Transaction History